L&C Bio Co. Ltd (290650) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.014x

Based on the latest financial reports, L&C Bio Co. Ltd (290650) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.79 Billion ≈ $2.57 Million USD) by net assets (₩266.71 Billion ≈ $180.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 290650 company net worth for the company's overall valuation and market capitalisation.

L&C Bio Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how L&C Bio Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

L&C Bio Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of L&C Bio Co. Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of L&C Bio Co. Ltd to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
CTO Realty Growth Inc NYSE:CTO	0.030x
Suzhou Keda Technology Co Ltd SHG:603660	-0.011x
Canadian General Investments Ltd TO:CGI	-0.004x
Lotte Confectionery Co Ltd KO:280360	0.018x
MBK Public Company Limited BK:MBK-R	0.028x
Zhejiang Zhaofeng Mechanical and Electronic Co Ltd SHE:300695	0.000x
Ardmore Shpng NYSE:ASC	0.041x
Yext Inc NYSE:YEXT	0.055x

Annual Cash Flow Conversion Efficiency for L&C Bio Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of L&C Bio Co. Ltd from 2015 to 2024. View 290650 stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩284.35 Billion ≈ $192.70 Million	₩-8.57 Billion ≈ $-5.81 Million	-0.030x	+63.51%
2023-12-31	₩146.94 Billion ≈ $99.58 Million	₩-12.13 Billion ≈ $-8.22 Million	-0.083x	-33.11%
2022-12-31	₩97.95 Billion ≈ $66.38 Million	₩-6.08 Billion ≈ $-4.12 Million	-0.062x	-148.35%
2021-12-31	₩85.02 Billion ≈ $57.62 Million	₩10.91 Billion ≈ $7.39 Million	0.128x	-0.05%
2020-12-31	₩57.81 Billion ≈ $39.17 Million	₩7.42 Billion ≈ $5.03 Million	0.128x	+16.12%
2019-12-31	₩58.18 Billion ≈ $39.43 Million	₩6.43 Billion ≈ $4.36 Million	0.111x	+50.78%
2018-12-31	₩52.46 Billion ≈ $35.55 Million	₩3.85 Billion ≈ $2.61 Million	0.073x	-67.72%
2017-12-31	₩16.81 Billion ≈ $11.39 Million	₩3.82 Billion ≈ $2.59 Million	0.227x	+1327.62%
2016-12-31	₩10.02 Billion ≈ $6.79 Million	₩-185.35 Million ≈ $-125.61K	-0.018x	+94.55%
2015-12-31	₩3.91 Billion ≈ $2.65 Million	₩-1.33 Billion ≈ $-899.78K	-0.339x	--

About L&C Bio Co. Ltd

KQ:290650 Korea Medical Devices

Market Cap

$775.80 Million

₩1.14 Trillion KRW

Market Cap Rank

#10101 Global

#266 in Korea

Share Price

₩46500.00

Change (1 day)

+1.75%

52-Week Range

₩45700.00 - ₩118300.00

All Time High

₩118300.00